Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

Phase 4 Study of Once-Daily Inhaled Glucocorticosteroid Administration in Asthma Patients

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Inclusion Criteria:

• Receive ICS for one year or more, with no change in dose within the previous 8 weeks

Exclusion Criteria:

• Two or more courses of oral corticosteroid in the previous 12 months
• Admission to hospital due to asthma in the previous 6 months
• Admission to the intensive care unit due to asthma at any time in the past
• Current cigarette smoker.